Seeking Alpha

JPMorgan calls today's weakness in GNC Holdings (GNC -4.4%) a "buying opportunity" after the FDA...

JPMorgan calls today's weakness in GNC Holdings (GNC -4.4%) a "buying opportunity" after the FDA warns about the dangers of stimulant DMAA. Analysts with the firm note that DMAA only makes up only a mid-single-digit percentage of GNC sales and the company plans to continue selling products with it despite the brouhaha.
Comments (1)
  • Diamond0000
    , contributor
    Comment (1) | Send Message
     
    Wont that affect GNC Tomorrow?
    30 Apr 2012, 05:10 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|